Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025
October 25, 2025 11:01 ET | Source: Cullinan Therapeutics, Inc. CLN-978 led…
CGTN: Restoring the History of Taiwan
BEIJING, Oct. 25, 2025 /PRNewswire/ -- Men forget, and history overlooks. But…
From India to the USA: HDFC ERGOs Guide to Why Travel Insurance is Essential
mumbai, India, Oct. 25, 2025 (GLOBE NEWSWIRE) -- A long flight, a…
Cyber Heater Unveiled: How the Smart Electric Cyber Heater Is Revolutionizing Home Warmth & Winter Comfort
New York City, NY, Oct. 25, 2025 (GLOBE NEWSWIRE) -- Introduction As…
No KYC Casinos 2025: Rakebit Rated as the Leading No Verification Online Casino
Baltimore, Maryland, Oct. 25, 2025 (GLOBE NEWSWIRE) -- RakeBit leads as no…
ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium
Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM),…
Aletheia Capital Endeavours Launches RepIntel, a Campaign-Grade Platform to Accelerate Global Access to Therapies
October 24, 2025 23:37 ET | Source: RepIntel. New York, New York,…
Prenetics Global Limited Announces Proposed Public Offering
October 24, 2025 20:30 ET | Source: Prenetics Global Limited CHARLOTTE, N.C.,…
COTHM Pakistan and MindHYVE.ai Forge Strategic Partnership to Pioneer AI-Powered Hospitality Education
LAHORE, Pakistan, Oct. 24, 2025 /PRNewswire/ -- The College of Tourism &…
Hope in Syria: Education Cannot Wait investments support teacher training and continued learning for displaced children in Syria
NEW YORK, Oct. 24, 2025 /PRNewswire/ -- In the heart of a…
